Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 774 posts found.

Astrazeneca image

AstraZeneca restructures global R&D

March 19, 2013
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, R&D

AstraZeneca is restructuring its global operations in a bid to improve the productivity of its R&D operations. The firm is …

News
Forxiga image

NICE rejects Forxiga

February 1, 2013
Sales and Marketing AstraZeneca, BMS, Forxiga, NICE, diabetes

NICE has given the thumbs-down to AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga. The drug was approved …

News
Astrazeneca image

AstraZeneca signs respiratory deal

January 29, 2013
Research and Development, Sales and Marketing AstraZeneca, COPD, orexo, respiratory

AstraZeneca has signed a research deal with Swedish pharma company Orexo centred around the development of respiratory disease treatments. For …

News
Astrazeneca image

AstraZeneca shakes up management

January 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Mackay, R&D, Soriot

AstraZeneca has taken its most dramatic steps yet to arrest decline, with chief executive Pascal Soriot axeing two senior positions …

News
Astrazeneca image

RA setbacks for AstraZeneca and Lilly

December 14, 2012
Research and Development, Sales and Marketing AstraZeneca, Humira, RA, lilly

AstraZeneca and Eli Lilly have both suffered setbacks in their attempts to push their respective investigational rheumatoid arthritis (RA) treatments …

News
Forxiga image

Forxiga approved in European Union

November 15, 2012
Sales and Marketing AstraZeneca, BMS, Forxiga, diabetes

AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga has been approved in Europe – a major filip for …

News

Germany dismisses Seroquel XR

November 14, 2012
Sales and Marketing AstraZeneca, FDA, Germany, Seroquel XR

AstraZeneca has received another dent in its international attempts to keep the money-spinning antipsychotic Seroquel going in a new form. …

News

AstraZeneca signs genome deal

November 13, 2012
Research and Development, Sales and Marketing AstraZeneca, Foundation, SMIP

AstraZeneca has signed a genomic profiling agreement with US molecular information company Foundation Medicine. The collaboration will use its FoundationOne …

News
Astrazeneca image

MRC gives £7 million to new projects

November 6, 2012
Sales and Marketing AstraZeneca, MRC, academics

The Medical Research Council (MRC) has handed out £7 million in funding for 15 research projects which will use a …

News
Astrazeneca image

Sharp fall for AstraZeneca

October 26, 2012
Sales and Marketing AstraZeneca, Brennan, Q3, Soriot

AstraZeneca saw its third quarter revenue and pre-tax profit both fall 15%, to $6.7 billion and $2 billion, respectively. The …

News
Astrazeneca image

AstraZeneca and Ironwood announce $150 million China pact

October 25, 2012
Research and Development, Sales and Marketing AstraZeneca, China, IBS, Ironwood

AstraZeneca has signed a deal with Ironwood to co-develop and co-market Ironwood’s irritable bowel syndrome treatment in China. In August …

News
Astrazeneca image

AZ licences renal disease compound

October 9, 2012
Research and Development, Sales and Marketing Ardelyx, AstraZeneca, NHE3

AstraZeneca has signed an agreement giving it worldwide exclusive rights to California-based Ardelyx’s NHE3 inhibitor programme targeting liver and kidney …

News

Pharma creates non-profit R&D organisation

September 21, 2012
Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma

Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …

News
Mark Mallon image

Asia-Pacific – pharma’s new centre of gravity?

September 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia-Pacific, AstraZeneca

A high-growth region for the pharmaceutical industry, Asia-Pacific incorporates a vast geography with a $20 trillion economy, and is home …

Feature
Astrazeneca image

AstraZeneca signs MIT/Harvard research deal

September 17, 2012
Business Services, Research and Development, Sales and Marketing AstraZeneca, Deals, Havard, MIT

AstraZeneca has signed a two-year collaboration with an academic institution – affiliated to the illustrious universities MIT and Harvard – …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024